BeOne Medicines (BEIGF) Goodwill & Intangibles (2017 - 2026)

BeOne Medicines (BEIGF) has 10 years of Goodwill & Intangibles data on file, last reported at $61.7 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $61.7 million, up 23.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.7 million (up 23.02% YoY), and the FY2025 annual result was $62.7 million, up 22.72% from the prior year.
• Goodwill & Intangibles eased to $61.7 million in Q1 2026 per BEIGF's latest filing, from $62.7 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $64.9 million in Q2 2025 and troughed at $39.7 million in Q1 2023.
• A 5-year average of $52.1 million and a median of $53.7 million in 2023 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles surged 851.73% in 2022, then fell 13.26% in 2023.
• A 5-year view of Goodwill & Intangibles shows it stood at $40.6 million in 2022, then surged by 40.68% to $57.1 million in 2023, then retreated by 10.58% to $51.1 million in 2024, then gained by 22.72% to $62.7 million in 2025, then retreated by 1.63% to $61.7 million in 2026.
• Business Quant data shows BEIGF's Goodwill & Intangibles at $61.7 million in Q1 2026, $62.7 million in Q4 2025, and $63.6 million in Q3 2025.